[1]
|
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021, 36(6): 521-545.
|
[2]
|
Benjamin, E.J., et al. (2017) Heart Disease and Stroke Statistics—2017 Update: A Report from the American Heart Association. Circulation, 135, e146-e603. https://doi.org/10.1161/CIR.0000000000000485
|
[3]
|
Ambrosy, A.P., et al. (2014) The Global Health and Eco-nomic Burden of Hospitalizations for Heart Failure. Journal of the American College of Cardiology, 63, 1123-1133. https://doi.org/10.1016/j.jacc.2013.11.053
|
[4]
|
Chaudhry, S. and Stewart, G.C. (2016) Advanced Heart Failure. Heart Failure Clinics, 12, 323-333.
https://doi.org/10.1016/j.hfc.2016.03.001
|
[5]
|
Rodriguez, L.E., et al. (2021) Ventricular Assist Devices (VAD) Therapy: New Technology, New Hope? Methodist DeBakey Cardiovascular Journal, 9, 32-37. https://doi.org/10.14797/mdcj-9-1-32
|
[6]
|
Garbade, J., et al. (2013) Heart Transplantation and Left Ventricular Assist Device Therapy: Two Comparable Options in End-Stage Heart Failure? Clinical Cardiology, 36, 378-382. https://doi.org/10.1002/clc.22124
|
[7]
|
Pinney, S.P., et al. (2017) Left Ventricular Assist Devices for Lifelong Support. Journal of the American College of Cardiology, 69, 2845-2861. https://doi.org/10.1016/j.jacc.2017.04.031
|
[8]
|
Kirklin, J.K., et al. (2017) Eighth Annual INTERMACS Report: Special Focus on Framing the Impact of Adverse Events. The Journal of Heart and Lung Transplantation, 36, 1080-1086. https://doi.org/10.1016/j.healun.2017.07.005
|
[9]
|
Shah, P., et al. (2022) Twelfth Interagency Registry for Mechanically Assisted Circulatory Support Report: Readmissions after Left Ventricular Assist Device. The Annals of Thoracic Surgery, 113, 722-737.
https://doi.org/10.1016/j.athoracsur.2021.12.011
|
[10]
|
管翔, 陈志远, 李庆国. 植入式心室辅助装置的研究进展[J]. 国际心血管病杂志, 2020, 47(2): 76-80.
|
[11]
|
Miller, L.W. and Guglin, M. (2013) Patient Selection for Ventricular Assist Devices. Journal of the American College of Cardiology, 61, 1209-1221. https://doi.org/10.1016/j.jacc.2012.08.1029
|
[12]
|
Birschmann, I., et al. (2014) Ambient Hemolysis and Activation of Coagulation Is Different Between HeartMate II and Heart Ware Left Ventricular Assist Devices. The Journal of Heart and Lung Transplantation, 33, 80-87.
https://doi.org/10.1016/j.healun.2013.11.010
|
[13]
|
Starling, R.C., et al. (2011) Results of the Post-U.S. Food and Drug Administration-Approval Study with a Continuous Flow Left Ventricular Assist Device as a Bridge to Heart Transplantation. Journal of the American College of Cardiology, 57, 1890-1898. https://doi.org/10.1016/j.jacc.2010.10.062
|
[14]
|
John, R., et al. (2011) Continuous Flow Left Ventricular Assist Device Outcomes in Commercial Use Compared with the Prior Clinical Trial. The Annals of Thoracic Surgery, 92, 1406-1413.
https://doi.org/10.1016/j.athoracsur.2011.05.080
|
[15]
|
Kannojiya, V., Das, A.K. and Das, P.K. (2021) Comparative Assessment of Different Versions of Axial and Centrifugal LVADs: A Review. Artificial Organs, 45, 665-681. https://doi.org/10.1111/aor.13914
|
[16]
|
Aaronson, K.D., et al. (2012) Use of An Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation. Circulation, 125, 3191-3200. https://doi.org/10.1161/CIRCULATIONAHA.111.058412
|
[17]
|
Dunlay, S.M., et al. (2014) Frailty and Outcomes after Implantation of Left Ventricular Assist Device as Destination Therapy. The Journal of Heart and Lung Trans-plantation, 33, 359-365. https://doi.org/10.1016/j.healun.2013.12.014
|
[18]
|
Adamson, R.M., et al. (2011) Clinical Strategies and Outcomes in Advanced Heart Failure Patients Older than 70 Years of Age Receiving the HeartMate II Left Ventricular Assist Device. Journal of the American College of Cardiology, 57, 2487-2495. https://doi.org/10.1016/j.jacc.2011.01.043
|
[19]
|
Schaffer, J.M., et al. (2009) Evaluation of Risk Indices in Con-tinuous-Flow Left Ventricular Assist Device Patients. The Annals of Thoracic Surgery, 88, 1889-1896. https://doi.org/10.1016/j.athoracsur.2009.08.011
|
[20]
|
Estep, J.D., et al. (2021) Continuous Flow Left Ventricular Assist Devices: Shared Care Goals of Monitoring and Treating Patients. Methodist DeBakey Cardiovascular Journal, 11, 33-44. https://doi.org/10.14797/mdcj-11-1-33
|
[21]
|
John, R., et al. (2009) Activation of Endothelial and Coagulation Systems in Left Ventricular Assist Device Recipients. The Annals of Thoracic Surgery, 88, 1171-1179. https://doi.org/10.1016/j.athoracsur.2009.06.095
|
[22]
|
Suarez, J., et al. (2011) Mechanisms of Bleeding and Ap-proach to Patients with Axial-Flow Left Ventricular Assist Devices. Circulation: Heart Failure, 4, 779-784. https://doi.org/10.1161/CIRCHEARTFAILURE.111.962613
|
[23]
|
Pratt, A.K., Shah, N.S. and Boyce, S.W. (2014) Left Ventricular Assist Device Management in the ICU. Critical Care Medicine, 42, 158-168. https://doi.org/10.1097/01.ccm.0000435675.91305.76
|
[24]
|
DeVore, A.D., Mentz, R.J. and Patel, C.B. (2014) Medical Management of Patients with Continuous-Flow Left Ventricular Assist Devices. Current Treatment Options in Cardiovascular Medicine, 16, Article No. 283.
https://doi.org/10.1007/s11936-013-0283-0
|
[25]
|
Bruckner, B.A., et al. (2009) High Incidence of Thromboembolic Events in Left Ventricular Assist Device Patients Treated with Recombinant Activated Factor VII. The Journal of Heart and Lung Transplantation, 28, 785-790.
https://doi.org/10.1016/j.healun.2009.04.028
|
[26]
|
Cleveland, J.J., et al. (2011) Survival after Biventricular Assist Device Implantation: An Analysis of the Interagency Registry for Mechanically Assisted Circulatory Support Database. The Journal of Heart and Lung Transplantation, 30, 862-869. https://doi.org/10.1016/j.healun.2011.04.004
|
[27]
|
Feldman, D., et al. (2013) The 2013 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: Executive Summary. The Journal of Heart and Lung Transplantation, 32, 157-187.
https://doi.org/10.1016/j.healun.2012.09.013
|
[28]
|
Kusne, S., et al. (2017) An ISHLT Consensus Document for Prevention and Management Strategies for Mechanical Circulatory Support Infection. The Journal of Heart and Lung Transplantation, 36, 1137-1153.
https://doi.org/10.1016/j.healun.2017.06.007
|
[29]
|
Martin, S.I. (2013) Infectious Complications of Mechanical Circulatory Support (MCS) Devices. Current Infectious Disease Reports, 15, 472-477. https://doi.org/10.1007/s11908-013-0366-9
|
[30]
|
Aissaoui, N., et al. (2012) HeartWare Continuous-Flow Ventric-ular Assist Device Thrombosis: The Bad Oeynhausen Experience. The Journal of Thoracic and Cardiovascular Surgery, 143, e37-e39.
https://doi.org/10.1016/j.jtcvs.2011.12.035
|
[31]
|
Greet, B.D., et al. (2018) Incidence, Predictors, and Significance of Ventricular Arrhythmias in Patients with Continuous-Flow Left Ventricular Assist Devices. JACC: Clinical Elec-trophysiology, 4, 257-264.
https://doi.org/10.1016/j.jacep.2017.11.001
|
[32]
|
Hamdan, R., Charif, F. and Kadri, Z. (2020) Right Ventricle Failure in Patients Treated with Left Ventricular Assist Device. Annales de Cardiologie et D’Angéiologie, 69, 51-54. https://doi.org/10.1016/j.ancard.2020.01.008
|
[33]
|
Potapov, E.V., et al. (2008) Tricuspid Incompetence and Ge-ometry of the Right Ventricle as Predictors of Right Ventricular Function after Implantation of a Left Ventricular Assist Device. The Journal of Heart and Lung Transplantation, 27, 1275-1281. https://doi.org/10.1016/j.healun.2008.08.012
|
[34]
|
Potapov, E., et al. (2011) Inhaled Nitric Oxide after Left Ven-tricular Assist Device Implantation: A Prospective, Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial. The Journal of Heart and Lung Transplantation, 30, 870-878. https://doi.org/10.1016/j.healun.2011.03.005
|
[35]
|
Klodell, C.T., et al. (2007) Effect of Sildenafil on Pulmonary Artery Pressure, Systemic Pressure, and Nitric Oxide Utilization in Patients with Left Ventricular Assist Devices. The Annals of Thoracic Surgery, 83, 68-71.
https://doi.org/10.1016/j.athoracsur.2006.08.051
|
[36]
|
Hamdan, R., et al. (2014) Prevention of Right Heart Failure after Left Ventricular Assist Device Implantation by Phosphodiesterase 5 Inhibitor. Artificial Organs, 38, 963-967. https://doi.org/10.1111/aor.12277
|
[37]
|
Theiss, H.D., et al. (2014) Preconditioning with Levosimendan before Implantation of Left Ventricular Assist Devices. Artificial Organs, 38, 231-234. https://doi.org/10.1111/aor.12150
|
[38]
|
Takeda, K., et al. (2014) Outcome of Unplanned Right Ventricular Assist Device Support for Severe Right Heart Failure after Implantable Left Ventricular Assist Device Insertion. The Journal of Heart and Lung Transplantation, 33, 141-148. https://doi.org/10.1016/j.healun.2013.06.025
|